Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
NCT01851642
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macrophages, and their ability to work.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Alpha-1 Antitrypsin Deficiency
- AAT Deficiency
- AATD
- Cystic Fibrosis (CF)
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of Florida
- Last updated on ClinicalTrials.gov
- November 6, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Shands at the University of Florida · Gainesville, FL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.